NYSE:CAH - Cardinal Health Stock Price, News, Headlines & Rumors

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health declared a quarterly dividend on Wednesday, August 8th. Investors of record on Monday, October 1st will be given a dividend of $0.4763 per share on Monday, October 15th. This represents a $1.91 annualized dividend and a yield of 3.78%. The ex-dividend date is Friday, September 28th. This is a boost from Cardinal Health's previous quarterly dividend of $0.48. View Cardinal Health's Dividend History.

Cardinal Health declared that its board has initiated a share buyback program on Thursday, February 8th 2018, which allows the company to buyback $1,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Stock buyback programs are often a sign that the company's management believes its shares are undervalued.

Cardinal Health Inc (NYSE:CAH) posted its quarterly earnings data on Monday, August, 6th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.93 by $0.08. The company had revenue of $35.35 billion for the quarter, compared to analyst estimates of $34.38 billion. Cardinal Health had a net margin of 0.19% and a return on equity of 22.59%. The firm's revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.31 earnings per share. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Monday, November, 5th 2018. View Earnings Estimates for Cardinal Health.

13 analysts have issued 12-month price targets for Cardinal Health's shares. Their predictions range from $40.00 to $75.00. On average, they expect Cardinal Health's stock price to reach $61.3333 in the next twelve months. This suggests a possible upside of 21.6% from the stock's current price. View Analyst Price Targets for Cardinal Health.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 2 sell ratings, 8 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cardinal Health.

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), Trxade Group (TRXD), biOasis Technologies (BIOAF) and Medizone International (MZEI).

Headlines about CAH stock have trended somewhat positive recently, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cardinal Health earned a news impact score of 0.24 on Accern's scale. They also gave news headlines about the company an impact score of 48.16 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days. View Recent Headlines for Cardinal Health.

Cardinal Health's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.80%), Macquarie Group Ltd. (4.04%), FMR LLC (2.71%), American International Group Inc. (2.44%), Bank of New York Mellon Corp (2.03%) and American Century Companies Inc. (1.44%). Company insiders that own Cardinal Health stock include George S Barrett, Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, TCW Group Inc., FMR LLC, Russell Investments Group Ltd., American International Group Inc., Bank of Montreal Can, Wells Fargo & Company MN and Bank of New York Mellon Corp. Company insiders that have sold Cardinal Health company stock in the last year include Jon L Giacomin, Michael C Kaufmann and Patricia Morrison. View Insider Buying and Selling for Cardinal Health.

CAH stock was purchased by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Millennium Management LLC, American Century Companies Inc., Brandes Investment Partners LP, Dimensional Fund Advisors LP, Los Angeles Capital Management & Equity Research Inc., Thompson Siegel & Walmsley LLC and Morgan Stanley. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $50.45.

Cardinal Health has a market capitalization of $15.04 billion and generates $136.81 billion in revenue each year. The company earns $256 million in net income (profit) each year or $5.00 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]